Zolmitriptan N-Oxide is an oxidized derivative of the parent drug zolmitriptan, featuring an N-oxide functional group on the piperazine nitrogen. Its structure retains the indole core, methoxyphenyl substituent, and triazole bridge characteristic of the parent compound, with the N-oxide introducing an electron-withdrawing effect that alters physicochemical properties. This impurity arises via oxidative degradation pathways, commonly observed under stress conditions during API synthesis or storage. It serves as a critical HPLC reference standard for quantifying oxidation-related impurities in zolmitriptan formulations.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1727064 ↗ | 25 mg | USD 838.00 |
C[N+](C)(CCC1=CNC2=C1C=C(C=C2)C[C@H]3COC(=O)N3)[O-]
InChI=1S/C16H21N3O3/c1-19(2,21)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-22-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
GZYCQRZFJIZOKU-ZDUSSCGKSA-N